Despite challenges in studying allergen-specific CD4+ T cells in food allergy, targeted approaches signal progress while emerging prospects show future promise.

These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...